Acceptance rate |
46% |
Time to first decision |
6 months* |
Time to decision with review |
50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2018 , Vol 56 , Num 1
Biosimilars: Current Scenario and Challenges in India
Anitha Nandagopal, Yusra Shakeel, Mamatha Tirunagari
DOI: 10.23893/1307-2080.APS.05601
Turkish Abstract
Abstract
PDF
Similar Articles
Mail to Author
Branding of Prescription and Non-prescription Drugs
Merve Memişoğlu
DOI: 10.23893/1307-2080.APS.05602
Turkish Abstract
Abstract
PDF
Similar Articles
Mail to Author
Proposal for an "Althaeae flos (marshmallow flower)" Monograph set-up based on European Pharmacopoeia Template and Quality Evaluation of Commercial Samples
Esra Saçıcı, Erdem Yeşilada
DOI: 10.23893/1307-2080.APS.05603
Turkish Abstract
Abstract
PDF
Similar Articles
Mail to Author
A Contraindication to Metformin Therapy: Renal Impairment - Adherence to Prescribing Guidelines at a Hospital in Turkey
Neda Taner, Büşra Nur Çattık, Barkın Berk
DOI: 10.23893/1307-2080.APS.05604
Turkish Abstract
Abstract
PDF
Similar Articles
Mail to Author
Estimation of Abiraterone in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry
Srinivasa Reddy, Licto Thomas, Lokesh Ramanna, Arindam Mukhopadhyay, Saral Thangam
DOI: 10.23893/1307-2080.APS.05605
Turkish Abstract
Abstract
PDF
Similar Articles
Mail to Author
Investigation of the Anti-inflammatory, Hypoglycemic Activity and Median Lethal Dose (LD50) Level of Limonene in Mice and Rats
Betül Sever Yılmaz, Hanefi Özbek
DOI: 10.23893/1307-2080.APS.05606
Turkish Abstract
Abstract
PDF
Similar Articles
Mail to Author
Potential Mechanistic Profiling of an OTC Analgesic as a Cytotoxic Agent in the Treatment of Hepatocellular Carcinoma
Marwa E. Sayour, Ibrahim Basheer, Rania Abd El Salam, Mohamed El Yamany, Amr Badr, Ahmed Farouk Al-Sadek, Raafat El-Awady
DOI: 10.23893/1307-2080.APS.05607
Turkish Abstract
Abstract
PDF
Similar Articles
Mail to Author